Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
[1] [7] The FDA-approved prescribing information specifies three anatomical sites for subcutaneous administration: the abdomen, thigh, and upper arm
Y.XueZ.WangT
Unexplained or debilitating fatigue
The accelerated approval was granted based on initial overall response rate (ORR) of 57% in 164 treatment-nave patients and duration of response (DOR)40% of responders had a duration of response greater than 12 months, according to the FDAs full approval announcement
Extended use isnt well-studied in humans, so most experts recommend cycling it, typically 48 weeks on, followed by a few weeks off, to support safety and effectiveness.
LIFEMD I was not offered compounded sema during intake
US$ 20.03
US$ 22.45
US$ 27.63
US$ 22.52
